Noss E H, Pai R K, Sellati T J, Radolf J D, Belisle J, Golenbock D T, Boom W H, Harding C V
Department of Pathology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.
J Immunol. 2001 Jul 15;167(2):910-8. doi: 10.4049/jimmunol.167.2.910.
Mycobacterium tuberculosis (MTB) induces vigorous immune responses, yet persists inside macrophages, evading host immunity. MTB bacilli or lysate was found to inhibit macrophage expression of class II MHC (MHC-II) molecules and MHC-II Ag processing. This report characterizes and identifies a specific component of MTB that mediates these inhibitory effects. The inhibitor was extracted from MTB lysate with Triton X-114, isolated by gel electroelution, and identified with Abs to be MTB 19-kDa lipoprotein. Electroelution- or immunoaffinity-purified MTB 19-kDa lipoprotein inhibited MHC-II expression and processing of both soluble Ags and Ag 85B from intact MTB bacilli. Inhibition of MHC-II Ag processing by either MTB bacilli or purified MTB 19-kDa lipoprotein was dependent on Toll-like receptor (TLR) 2 and independent of TLR 4. Synthetic analogs of lipopeptides from Treponema pallidum also inhibited Ag processing. Despite the ability of MTB 19-kDa lipoprotein to activate microbicidal and innate immune functions early in infection, TLR 2-dependent inhibition of MHC-II expression and Ag processing by MTB 19-kDa lipoprotein during later phases of macrophage infection may prevent presentation of MTB Ags and decrease recognition by T cells. This mechanism may allow intracellular MTB to evade immune surveillance and maintain chronic infection.
结核分枝杆菌(MTB)可引发强烈的免疫反应,但却能在巨噬细胞内存活,逃避宿主免疫。研究发现,MTB杆菌或其裂解物可抑制巨噬细胞II类主要组织相容性复合体(MHC-II)分子的表达以及MHC-II抗原处理过程。本报告对MTB中介导这些抑制作用的特定成分进行了表征和鉴定。该抑制剂用Triton X-114从MTB裂解物中提取,通过凝胶电洗脱法分离,并用抗体鉴定为MTB 19-kDa脂蛋白。经电洗脱或免疫亲和纯化的MTB 19-kDa脂蛋白可抑制MHC-II的表达以及可溶性抗原和完整MTB杆菌中Ag 85B抗原的处理。MTB杆菌或纯化的MTB 19-kDa脂蛋白对MHC-II抗原处理的抑制作用依赖于Toll样受体(TLR)2,而与TLR 4无关。梅毒螺旋体脂肽的合成类似物也可抑制抗原处理。尽管MTB 19-kDa脂蛋白在感染早期具有激活杀菌和固有免疫功能的能力,但在巨噬细胞感染后期,MTB 19-kDa脂蛋白对MHC-II表达和抗原处理的TLR 2依赖性抑制可能会阻止MTB抗原的呈递并减少T细胞的识别。这种机制可能使细胞内的MTB逃避免疫监视并维持慢性感染。